Published on
16:55 GMT
FDA Layoffs, Funding Cuts Cast Shadow Over Biopharma Industry
Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon expected to pull back from the biotech industry, representing a blow to a primary engine of the Boston area’s economic growth. Local …
Source:
The Harvard Crimson - Massachusetts
-
Neutral
